Does breath carbon monoxide measure nicotine dependence?

Journal of Addictive Diseases

Volumn 29, Issue 4, 2010, Pages 493-499

  Kapusta, Nestor D ^a   Pietschnig, Jakob ^a   Plener, Paul L ^b   Blüml, Victor ^a   Lesch, Otto M ^a   Walter, Henriette ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

carbon monoxide; Heaviness of Smoking Index; HSI; nicotine dependence; sensitivity; smoking; specificity

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ADULT; AREA UNDER THE CURVE; ARMY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; TOBACCO DEPENDENCE;

ADOLESCENT; BREATH TESTS; CARBON MONOXIDE; HUMANS; MALE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SMOKING; TOBACCO USE DISORDER;

EID: 77957921836     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2010.509280     Document Type: Article

References (62)

1. Ashton A, Telford R. Letter: blood carboxy-haemoglobin levels in smokers. Br Med J 1973; 4:740.
2. Rea JN, Tyrer PJ, Kasap, HS, Beresford SA. Expired air carbon monoxide, smoking, and other variables: a community study. Br J Prev Soc Med 1973; 27: 114-20.
3. Vogt TM, Selvin S, Widdowson G, Hulley SB. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health 1977; 67:545-9.
4. Jarvis MJ, Belcher M, Vesey C, Hutchison DC. Low cost carbon monoxide monitors in smoking assessment. Thorax 1986; 41:886-7.
5. Stookey GK, Katz BP, Olson BL, Drook CA, Cohen SJ. Evaluation of biochemical validation measures in determination of smoking status. J Dent Res 1987; 66:1597-601.
6. Petitti DB, Friedman GD, Kahn W. Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health 1981; 71:308-11.
7. Lando HA, McGovern PG, Kelder SH, Jeffery RW, Forster JL. Use of carbon monoxide breath validation in assessing exposure to cigarette smoke in a worksite population. Health Psychol 1991; 10:296-301.
8. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994; 84:1086-93.
9. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84:791-9.
10. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12:159-82.
11. John U, Meyer C, Schumann A, Hapke U, Rumpf HJ, Adam C, Alte D, Lüdemann J. A short form of the Fagerstrom Test for Nicotine Dependence and the Heaviness of Smoking Index in two adult population samples. Addict Behav 2004; 29:1207-12.
12. Burling AS, Burling TA. A comparison of self-report measures of nicotine dependence among male drug/alcohol-dependent cigarette smokers. Nicotine Tob Res 2003; 5:625-33.
13. Huang CL, Lin HH, Wang HH. Evaluating screening performances of the Fagerstrom tolerance questionnaire, the Fagerstrom test for nicotine dependence and the heavy smoking index among Taiwanese male smokers. J Clin Nurs 2008; 17:884-90.
14. Chaiton MO, Cohen JE, McDonald PW, Bondy SJ. The Heaviness of Smoking Index as a predictor of smoking cessation in Canada. Addict Behav 2007; 32:1031-42.
15. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994; 34:211-6.
16. Uysal MA, Kadakal F, Karsidag C, Bayram NG, Uysal O, Yilmaz V. Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks 2004; 2:115-21.
17. de Meneses-Gaya C, Zuardi AW, de Azevedo Marques JM, Souza RM, Loureiro SR, Crippa JA. Psychometric qualities of the Brazilian versions of the Fagerstrom Test for Nicotine Dependence and the Heaviness of Smoking Index. Nicotine Tob Res 2009; 11:1160-5.
18. Etter JF, Duc TV, Perneger TV. Validity of the Fager-strom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction 1999; 94:269-81.
19. Chabrol H, Niezborala M, Chastan E, de Leon J. Comparison of the Heavy Smoking Index and of the Fager-strom Test for Nicotine Dependence in a sample of 749 cigarette smokers. Addict Behav 2005; 30:1474-7.
20. Diaz FJ, Jane M, Salto E, Pardell H, Salleras L, Pinet C, de Leon J. A brief measure of high nicotine dependence for busy clinicians and large epidemiological surveys. Aust N Z J Psychiatry 2005; 39:161-8.
21. Etter JF, Pelissolo A, Pomerleau CS, de Saint-Hilaire Z. Associations between smoking and heritable temperament traits. Nicotine Tob Res 2003; 5:401-9.
22. Etter JF. A comparison of the content-, construct-and predictive validity of the cigarette dependence scale and the Fagerstrom test for nicotine dependence. Drug Alcohol Depend 2005; 77:259-68.
23. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK, Heath AC, Madden PA. Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 2004; 34:865-79.
24. Haberstick BC, Timberlake D, Ehringer MA, Lessem JM, Hopfer CJ, Smolen A, Hewitt JK. Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 2007; 102:655-65.
25. Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, Baker TB, Piper ME, McCarthy DE, Bolt, DM, Smith SS, Kim SY, Colby S, Conti D, Giovino GA, Hatsukami D, Hyland A, Krishnan-Sarin S, Niaura R, Perkins KA, Toll BA. Time to first cigarette in the morning as an index of ability to quit smoking: impli cations for nicotine dependence. Nicotine Tob Res 2007; 9 Suppl 4:S555-70.
26. Beuten J, Ma JZ, Lou XY, Payne TJ, Li MD. Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European-and African-American smokers. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:285-90.
27. Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, Somes G, Williams NJ, Elston RC, Li MD. Single-and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 2005; 76:859-64.
28. Beuten J, Payne TJ, Ma JZ, Li MD. Significant association of catechol-O-methyltransferase (COMT) haplo-types with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006; 31:675-84.
29. Chen GB, Payne TJ, Lou XY, Ma JZ, Zhu J, Li MD. Association of amyloid precursor protein-binding protein, family B, member 1 with nicotine dependence in African and European American smokers. Hum Genet 2008; 124:393-8.
30. Huang W, Payne TJ, Ma JZ, Li MD. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:1109-15.
31. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD. Significant association of DRD1 with nicotine dependence. Hum Genet 2008; 123:133-40.
32. Li MD. Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum Genet 2008; 123:119-31.
33. Li MD, Beuten J, Ma JZ, Lou XY, Garcia V, Duenes AS, Crews KM, Elston RC. Ethnic-and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 2005; 14:1211-9.
34. Li MD, Ma JZ, Payne TJ, Lou XY, Zhang D, Dupont RT, Elston RC. Genome-wide linkage scan for nicotine dependence in European Americans and its converging results with African Americans in the Mid-South Tobacco Family sample. Mol Psychiatry 2008; 13:407-16.
35. Li MD, Sun D, Lou XY, Beuten J, Payne TJ, Ma JZ. Linkage and association studies in African-and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence. Mol Psychiatry 2007; 12:462-73.
36. Liu YZ, Pei YF, Guo YF, Wang L, Liu XG, Yan H, Xiong DH, Zhang YP, Levy S, Li J, Haddock CK, Papasian CJ, Xu Q, Ma JZ, Payne TJ, Recker RR, Li MD, Deng HW. Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol Psychiatry 2009; 14:668-80.
37. Lou XY, Ma JZ, Payne TJ, Beuten J, Crew KM, Li MD. Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence. Hum Genet 2006; 120:381-9.
38. Lou XY, Ma JZ, Sun D, Payne TJ, Li MD. Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Hum Mol Genet 2007; 16:142-53.
39. Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 2005; 14:1691-8.
40. Mangold JE, Payne TJ, Ma JZ, Chen G, Li MD. Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans. J Med Genet 2008; 45:578-82.
41. Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J, Li MD. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European-and African-American smokers. Hum Mol Genet 2008; 17:1569-77.
42. Sun D, Ma JZ, Payne TJ, Li MD. Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. Mol Psychiatry 2008; 13: 398-406.
43. Xu Q, Huang W, Payne TJ, Ma JZ, Li MD. Detection of genetic association and a functional polymorphism of dynamin 1 gene with nicotine dependence in European and African Americans. Neuropsychopharmacology 2009; 34:1351-9.
44. Kapusta ND, Plener PL, Schmid R, Thau K, Walter H, Lesch OM. Multiple substance use among young males. Pharmacol Biochem Behav 2007; 86:306-11.
45. Heatherton TF, Kozlowski LT, Frecker RC, Fager-strom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119-27.
46. Glass GV, Peckham PD, Sanders JR. Consequences of failure to meet assumptions underlying the fixed effects analyses of variance and covariance. Review of Educational Research 1972; 42:237-88.
47. Harwell M. Summarizing Monte Carlo results in methodological research: the single-factor, fixed-effects ANCOVA case. JEBS 2003; 28:45-70.
48. Abrams DB, Follick MJ, Biener L, Carey KB, Hitti J. Saliva cotinine as a measure of smoking status in field settings. Am J Public Health 1987; 77:846-8.
49. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77:1435-8.
50. Pearce MS, Hayes L. Self-reported smoking status and exhaled carbon monoxide: results from two population-based epidemiologic studies in the North of England. Chest 2005; 128:1233-8.
51. Low ECT, Ong MCC, Tan M. Breath carbon monoxide as an indication of smoking habit in the military setting. Singapore Med J 2004; 45:578-82.
52. Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest 2000; 117: 758-63.
53. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005; 100:159-67.
54. Jones AYM, Lam PKW. End-expiratory carbon monoxide levels in healthy subjects living in a densely populated urban environment. Sci Total Environ 2006; 354:150-6.
55. Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M. Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest 2003; 124:1749-54.
56. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 1984; 38:335-9.
57. Robertson AS, Burge PS, Cockrill BL. A study of serum thiocyanate concentrations in office workers as a means of validating smoking histories and assessing passive exposure to cigarette smoke. Br J Ind Med 1987; 44:351-4.
58. Hendricks PS, Prochaska JJ, Humfleet GL, Hall SM. Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction 2008; 103:1215-23.
59. Mitchell SH. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 1999; 146:455-64.
60. Boffetta P, Pershagen G, Joeckel K-H, Forastiere F, Gaborieau V, Heinrich J, Jahn I, Kreuzer M, Merletti F, Nyberg F, Roesch F, Simonato L. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 1999; 91:697-701.
61. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am J Public Health 1993; 83:1251-7.
62. De Leon J, Susce MT, Diaz FJ, Rendon DM, Ve l ásquez DM. Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry 2005; 66:1447-55.